PV Bulletin
PvBulletin

Tag archive

Risk Management

Country GuidesHealth CanadaCanada

Health Canada updates RMP submission guidance effective 1 July 2025

Relevant for
Local Safety OfficerSignal Management LeadLabeling LeadRegulatory Intelligence Lead+3 more
Action needed

1) Retrieve and review the updated “Submitting risk management plans guidance document” (PDF) and linked templates referenced from the overview (e.g., RMP note to reviewer, Canadian-specific addendum, RMP summary template) and map deltas vs the superseded 2015 approach. 2) Update Canada submission checklists/work instructions for the 1 July 2025 effective date, including the requirement that the RMP include a summary in English and French and use of the RMP summary attestation/acknowledgment form. 3) Ask Regulatory Intelligence/RA to brief PV leadership on the Agile Licensing notice timeline (RMP provisions in force 1 April 2027) and confirm how transitional provisions will be operationalized for existing RMPs submitted prior to that date.

Process impact
Label GovernanceRisk ManagementLocal Affiliate Compliance
SOP impact

5 SOPs may need review

Urgency: HighConfidence: high
Read impact brief
AI/GxPFdaUnited Kingdom

MHRA updates SaMD/AIaMD guidance, highlighting PCCP and transparency principles

Relevant for
Signal Management LeadRegulatory Intelligence LeadMedical Device Vigilance LeadPV Quality Lead+2 more
Action needed

Ask the safety/device vigilance and PV CSV leads to: (1) confirm whether any marketed/fielded SaMD/AIaMD uses adaptive ML or planned updates that would fit a PCCP-like approach; (2) review current change-control SOPs and technical documentation to ensure change governance and transparency artifacts are captured and retrievable; (3) verify post-market/vigilance processes explicitly account for algorithm updates (e.g., monitoring after updates, escalation criteria).

Process impact
Risk ManagementDevice VigilanceInspection Readiness
SOP impact

5 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
Country GuidesMhra

UK MHRA refreshes PV procedures and adds decentralised manufacture UK GVP

Relevant for
Local Safety OfficerSignal Management LeadRegulatory Intelligence LeadPV Operations Lead+4 more
Action needed

Mhra update requires triage for Signal Validation, Risk Management, Local Affiliate Compliance; confirm local obligations and document follow-up actions.

Process impact
Signal ValidationRisk ManagementLocal Affiliate Compliance
SOP impact

9 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
RegulatorsTgaAustralia

TGA safety updates add warnings for GLP-1s, fluoroquinolones, RSV vaccines

Relevant for
Local Safety OfficerSignal Management LeadLabeling LeadRegulatory Intelligence Lead+2 more
Action needed

Tga update requires triage for Label Governance, Signal Validation, Risk Management; confirm local obligations and document follow-up actions.

Process impact
Label GovernanceSignal ValidationRisk Management
SOP impact

6 SOPs may need review

Urgency: MediumConfidence: medium
Read impact brief
LatestEma

MaaT Pharma flags CHMP “negative trend” ahead of June vote

Relevant for
Signal Management LeadLabeling LeadRegulatory Intelligence LeadPV Technology / CSV Lead+2 more
Action needed

Ema update requires triage for Label Governance, Risk Management, AI / GxP Governance; confirm local obligations and document follow-up actions.

Process impact
Label GovernanceRisk ManagementAI / GxP Governance
SOP impact

5 SOPs may need review

Urgency: MediumConfidence: medium
Read impact brief

Get updates for your PV role

Subscribe to receive impact-first pharmacovigilance updates tailored by role and workflow.

Current context: role Regulatory Intelligence Lead, workflow All.